Observed risk of recurrent bleeding and thromboembolic disease in COVID-19 patients with gastrointestinal bleeding

Background and study aim  COVID-19 patients are at increased risk for venous thromboembolism (VTE) requiring the use of anticoagulation. Gastrointestinal bleeding (GIB) is increasingly being reported, complicating the decision to initiate or resume anticoagulation as providers balance the risk of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Attah, Emmanuel, Martin, Tracey A., Smith, Emily S., Tewani, Sunena, Hajifathalian, Kaveh, Sharaiha, Reem Z., Crawford, Carl V., Wan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382501/
https://www.ncbi.nlm.nih.gov/pubmed/34466370
http://dx.doi.org/10.1055/a-1497-1801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382501/
https://www.ncbi.nlm.nih.gov/pubmed/34466370
http://dx.doi.org/10.1055/a-1497-1801

Ejemplares similares